pharmaphorum

JANUARY 18, 2022

million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. Primary Packaging material designers. Secondary packagers. Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. The global pre-filled syringes market was valued at $1139.6

Packaging 52

Packaging FDA Documentation Vaccines 52

European Pharmaceutical Review

FEBRUARY 7, 2023

Launch of the EU pharmaceutical package The European Commission plans to commence initiatives relating to the European Pharmaceutical Strategy (strategy) with the publication of the revised EU pharmaceutical package scheduled during the first quarter of 2023. of the MDR and Article 110.4

Packaging 117

Packaging 117

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.

Immunization 105

Immunization Packaging Labelling FDA 105

Viseven

JUNE 12, 2023

from 2022 to 2027. Main Potential of Pharma in the Asia-Pacific Region What role does the APAC region play in transforming today’s worldwide pharma market? This role is significant because the pharma market in APAC is increasing. According to one forecast, researchers anticipate that APAC pharma will grow 4.2% And it makes sense.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

ISPE

MARCH 8, 2023

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

ISPE

MARCH 15, 2023

4 The biopharmaceutical industry is taking steps to increase its environmental sustainability, 5 which begins with identifying and testing alternatives to existing procurement, materials, logistics, equipment, services, manufacturing processes, packaging, and facility design 6 (see Table 1). A Strategy for the Sector 2023–2027.”

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

STAT

JULY 25, 2023

The House Ways & Means Committee proposed a package that includes a new provision to ensure Medicare patients pay for medicines they pick up at pharmacies based on discounted prices insurers negotiate with drugmakers, instead of higher list prices, starting in 2027 , STAT reports.

Insurance 98

Insurance Packaging Hospitals 98

BuzzRx

AUGUST 30, 2022

This law includes a broad package of provisions concerning healthcare, taxes, and climate change. The Trump Administration’s drug rebate rule will be delayed until 2032 The Inflation Reduction Act includes a provision to delay the implementation of the Trump administration’s drug rebate rule from 2027 to 2032.

Vaccines 52

Vaccines Insurance Packaging Immunization 52